Celldex Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Private Companies | 3,124 | 0.00474% |
| Individual Insiders | 179,168 | 0.272% |
| General Public | 2,732,456 | 4.15% |
| Hedge Funds | 3,463,201 | 5.25% |
| Institutions | 59,532,599 | 90.3% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 39.5%.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 7,050,337 | €278.6m | -0.55% | 0.02% | |||
| 6,476,561 | €256.0m | 19.2% | 0.04% | |||
| 3,675,692 | €145.3m | 13% | no data | |||
| 3,630,013 | €143.5m | 127% | 2.59% | |||
| 3,463,201 | €136.9m | 0% | 2.51% | |||
| 3,135,871 | €123.9m | 29.2% | 0.57% | |||
| 3,046,331 | €120.4m | 16.3% | no data | |||
| 3,005,904 | €118.8m | -6.07% | 9.32% | |||
| 2,756,122 | €108.9m | 105% | 0.25% | |||
| 2,416,296 | €95.5m | 27.2% | 1.13% | |||
| 2,377,326 | €94.0m | 3.68% | no data | |||
| 2,225,448 | €88.0m | 20.2% | 0.06% | |||
| 1,280,084 | €50.6m | 138% | 0.12% | |||
| 1,117,994 | €44.2m | 11.8% | no data | |||
| 993,803 | €39.3m | -39.3% | 1.66% | |||
| 969,646 | €38.3m | 93.9% | 1.12% | |||
| 844,008 | €33.4m | 98.9% | 2.69% | |||
| 754,107 | €29.8m | 28.2% | 2.6% | |||
| 707,526 | €28.0m | -6.89% | 5.13% | |||
| 701,967 | €27.7m | -0.66% | 1.9% | |||
| 688,080 | €27.2m | 3,330% | 0.02% | |||
| 633,316 | €25.0m | 23.7% | no data | |||
| 497,270 | €19.7m | 60.3% | 3.96% | |||
| 475,000 | €18.8m | 0% | 2.09% | |||
| 444,805 | €17.6m | -6.14% | no data |